All In Biotech

Drug Trial Radar · NCT06708845

US Zamto-cel Autoimmune Diseases

A Phase I Multicohort Trial of Zamtocabtagene Autoleucel (Zamto-Cel) in Subjects With Severe Refractory Autoimmune Diseases

Last checked: Nov 20, 2026Latest source record: Jun 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

48

Planned (sponsor's estimate)

Start

Jul 2026

Primary completion

Jan 2028

Study completion Jul 2028

Sponsor

Lead sponsor
Miltenyi Biomedicine GmbHIndustry
Sponsor type
Industry
First posted
Nov 27, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

AID is a phase I multi-cohort study to assess the safety and tolerability of zamtocabtagene autoleucel (zamto-cel) in patients with refractory autoimmune diseases (SLE-Non renal, SLE-LN, SSc/dcSSc) after receiving standard therapy.

Conditions

  • Lupus Nephritis
  • Systemic Lupus Erythematosus
  • Systemic Sclerosis (SSc)
  • Diffuse Cutaneous Systemic Sclerosis

Interventions

  • zamtocabtagene autoleucelBiological

    chimeric antigen receptor T-cell (CAR-T) therapy

  • CyclophosphamideDrug

    Lymphodepleting chemotherapy

  • FludarabineDrug

    Lymphodepleting chemotherapy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The incidence and severity of adverse events (AEs), adverse events of special interest (AESIs), and serious adverse events (SAEs)Time frame: From enrollment through study completion 12 months post zamto-cel infusion
  2. The proportion of subjects with dose-limiting toxicities (DLTs) up to Day 28 and determination of recommended Phase 2 dose (RP2D)Time frame: From enrollment through Day 28 post zamto-cel infusion

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Froedtert Hospital and the Medical College of Wisconsin

    Milwaukee, Wisconsin · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.